Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from MedX Health ( (TSE:MDX) ).
MedX Health Corp. has appointed John Gevisser as its new CEO, who brings extensive experience in digital health and international growth strategies. Gevisser aims to expand MedX’s global presence and enhance the commercialization of its teledermatology platform, focusing on providing scalable, non-invasive skin assessment technology to at-risk populations through occupational healthcare and insurance providers worldwide.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. The company offers proprietary SIAscopy® technology integrated into the DermSecure® platform, which allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. Their products are approved for use in Canada, the U.S., Australia, New Zealand, the UK, the EU, and Turkey.
Average Trading Volume: 142,093
Technical Sentiment Signal: Buy
Current Market Cap: C$25.65M
For detailed information about MDX stock, go to TipRanks’ Stock Analysis page.